Daniels says the shortage of brand name drugs like glucagon-like peptide-1 (GLP-1) medications to treat diabetes and obesity ...

The School of Management and the School of Pharmacy and Pharmaceutical Sciences jointly offer a five-year program leading to the Master of Business Administration (MBA)/Doctor of Pharmacy (PharmD) ...

Chelsee Jensen, PharmD, BCPS, senior pharmacy specialist at Mayo Clinic, suggests that medical providers can reduce patient ...

The pharmacy practice four-year professional program, enables one to work as a licensed pharmacist, interacting with patients and other health care practitioners for matters involving treatment by ...

Students completing this program will earn a Doctor of Pharmacy degree and a Master of Business Administration degree. The applicant must notify both Colleges that he or she is applying for the dual ...

The phase 3 LEAP-015 trial evaluated the efficacy and safety of pembrolizumab with lenvatinib in patients with advanced/metastatic gastroesophageal cancer.

Opthea (ASX/NASDAQ:OPT) is a biopharmaceutical company developing novel therapies to treat vision-threatening eye diseases, including wet age‐related macular degeneration (wet AMD) and diabetic ...

The PharmD/MHA program combines a professional, patient-oriented qualification with a master’s degree that provides the systems level thinking needed by health care leaders. This program builds on the ...